Serial 99263451
Live / Allowed — Publication / registration review complete (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99263451
- Mark type
- Design / logo
- Filed
- 02 Jul 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Heather J. Kliebenstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer; antifungal preparations; antiparasitic preparations; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hematology diseases
- Class 042 — Scientific and technological services: Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for others; scientific research for medical purposes in the field of oncology
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the field of hematologic malignancies
Owner
- Quetzal Therapeutics, LLC, Chicago, IL, US
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 12 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 12 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 18 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Nov 2025 — NON-FINAL ACTION E-MAILED
- 21 Nov 2025 — NON-FINAL ACTION WRITTEN
- 08 Nov 2025 — ASSIGNED TO EXAMINER
- 06 Nov 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 06 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED